Literature DB >> 6384371

Humoral immunity in experimental syphilis: the demonstration of IgG as a treponemicidal factor in immune rabbit serum.

D R Blanco, J N Miller, P A Hanff.   

Abstract

The neutralizing activity present in immune rabbit serum (IRS) against virulent Treponema pallidum was shown to be mediated by IgG and complement. IgG was isolated and purified from both IRS and nonimmune rabbit serum (NRS) by the use of an affinity system in which staphylococcal protein A was conjugated to Sepharose 4B. The purity of the isolated IgG fractions was demonstrated by both immunoelectrophoresis and SDS-polyacrylamide gel electrophoresis. Fractions of IgG were tested for specific neutralizing activity as measured by an in vitro-in vivo neutralization test. Lesions failed to develop at 80% of the sites inoculated with treponemal suspensions containing IgG from IRS in the presence of unheated NRS as a source of complement; delayed atypical lesions were observed at the remaining sites. In contrast, typical lesions developed at all sites inoculated with suspensions containing IgG from IRS in the presence of heated NRS. They were significantly delayed, however, as compared with lesion development at control sites inoculated with suspensions containing IgG from NRS. These results provide the first direct evidence for an IgG complement-mediated treponemicidal mechanism operative in immune serum from rabbits with latent syphilis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6384371

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Antibody responses elicited against the Treponema pallidum repeat proteins differ during infection with different isolates of Treponema pallidum subsp. pallidum.

Authors:  Brandon T Leader; Karin Hevner; Barbara J Molini; Lynn K Barrett; Wesley C Van Voorhis; Sheila A Lukehart
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

Review 2.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Acquired resistance and expression of a protective humoral immune response in guinea pigs infected with Treponema pallidum Nichols.

Authors:  C S Pavia; C J Niederbuhl
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

4.  CD4+ lymphocytes and gamma interferon predominate in local immune responses in early experimental syphilis.

Authors:  Brandon T Leader; Charmie Godornes; Wesley C VanVoorhis; Sheila A Lukehart
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

5.  Antimicrobial activity of rabbit leukocyte defensins against Treponema pallidum subsp. pallidum.

Authors:  L A Borenstein; M E Selsted; R I Lehrer; J N Miller
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

6.  Correlation of immunity in experimental syphilis with serum-mediated aggregation of Treponema pallidum rare outer membrane proteins.

Authors:  M A Lewinski; J N Miller; M A Lovett; D R Blanco
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

7.  Enhanced primary resistance to Treponema pallidum infection and increased susceptibility to toxoplasmosis in T-cell-depleted guinea pigs.

Authors:  C S Pavia
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

8.  Evaluation of the cross-reaction between anti-DNA and anti-cardiolipin antibodies in SLE and experimental animals.

Authors:  D Eilat; A Y Zlotnick; R Fischel
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

9.  Cyclophosphamide-sensitive activity of suppressor T cells during treponemal infection.

Authors:  D R Tabor; D P Kiel; R F Jacobs
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

10.  The surface of virulent Treponema pallidum: resistance to antibody binding in the absence of complement and surface association of recombinant antigen 4D.

Authors:  J D Radolf; T E Fehniger; F J Silverblatt; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.